共 82 条
Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
被引:55
作者:
Drew, Richard H.
[1
,2
]
White, Roger
[3
]
MacDougall, Conan
[4
]
Hermsen, Elizabeth D.
[5
,6
,7
]
Owens, Robert C., Jr.
[8
,9
]
机构:
[1] Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA
[2] Campbell Univ, Coll Pharm, Buies Creek, NC 27506 USA
[3] S Carolina Coll Pharm, Charleston, SC USA
[4] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[5] Univ Nebraska Med Ctr, Antimicrobial Stewardship Program, Omaha, NE USA
[6] Univ Nebraska Med Ctr, Coll Pharm, Omaha, NE USA
[7] Univ Nebraska Med Ctr, Coll Med, Omaha, NE USA
[8] Maine Med Ctr, Antimicrobial Stewardship Program, Portland, ME 04102 USA
[9] Univ Vermont, Coll Med, Burlington, VT USA
来源:
PHARMACOTHERAPY
|
2009年
/
29卷
/
05期
关键词:
antimicrobial stewardship;
guidelines;
infectious diseases;
EMPIRIC ANTIBIOTIC SCHEDULE;
BLOOD-STREAM INFECTIONS;
STAPHYLOCOCCUS-AUREUS;
CEPHALOSPORIN RESISTANCE;
CLOSTRIDIUM-DIFFICILE;
METHICILLIN-RESISTANT;
VANCOMYCIN-RESISTANT;
FLUOROQUINOLONE USE;
MANAGEMENT PROGRAM;
COST-EFFECTIVENESS;
D O I:
10.1592/phco.29.5.593
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
In 2007, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America published a document that addressed the major considerations for the justification, description, and conduct of antimicrobial stewardship programs. Our document is intended to continue the dialogue of these formalized programmatic strategies. We briefly review the guidelines, including the two primary strategies (prospective auditing with feedback, and preauthorization), and the supplemental strategies (education, information technology, transitional therapy, deescalation or streamlining, and dose optimization). Discussions are introduced or furthered in the areas of program goals, barriers and Solutions, and outcome measures. Definition and training of infectious diseases pharmacists are presented in detail. We offer keys to future success, which include Continued collaboration and expanded use of information technology
引用
收藏
页码:593 / 607
页数:15
相关论文